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Summary Conditioned media from 14 short term fibroblast cell lines were mitogenic for human breast cancer
cells with different steroid receptor profiles in serum-free culture. Fibroblast-conditioned medium stimulated
tritiated thymidine incorporation in short term culture and growth in a longer proliferation study as measured
by the MTT colourimetric assay.
Conditioned media from benign and malignant epithelial cells were non-stimulatory for breast cancer cells
but that derived from endothelial cells showed similar stimulation to fibroblasts.
Partial purification of fibroblast-conditioned medium identified a peptide with a molecular weight of
approximately 8 kDa that showed no affinity for heparin and was mitogenic for MCF-7 breast cancer cells.
There is evidence for autocrine control of human breast
cancer growth, through endogenous or oestrogen controlled
production of polypeptide growth factors (Lippman et al.,
1986a; 1986b; Cullen et al., 1989). It has also been proposed
that paracrine interactions between stromal tissue and malig-
nant epithelia play an important role in the development and
control of human breast cancer (Lippman et al., 1986a;
1986b; Cullen et al., 1989). Human breast cancer cells have
been shown to express growth factors for mesenchymal cells
(Rozengurt et al., 1985; Peres et al., 1987), suggesting a
molecular basis for the generation of tumour stroma. There
is controversy however as to whether neighbouring stromal
tissue cells secrete soluble factors that regulate the growth of
malignant epithelia (Yee et al., 1988; 1989; Cullen et al.,
1991; Clarke et al., 1992). Although studies have demon-
strated that fibroblasts increased the growth of human breast
cancer cells, the evidence remains inconclusive as to the
extent and nature of the paracrine stimulation.
This laboratory (Horgan et al., 1987) and others (Camps et
al., 1990) have reported that co-inoculation of human breast
cancer cells and fibroblasts increased both the 'take' and size
of xenotransplants in athymic mice. Fibroblasts that had
been pre-treated with glutaraldehyde increased MCF-7 tum-
our take but not growth (Horgan et al., 1987), whereas
lethally irradiated fibroblasts (Picard et al., 1986; Camps et
al., 1990) and fibroblast-conditioned medium (Picard et al.,
1986) stimulated tumour growth, though to a lesser extent
than live fibroblasts. This suggests that tumour take is
induced by an inert fibroblast factor, whereas maximal
growth stimulation of malignant epithelia required the con-
tinuous supply of a tumour promoting factor by the interac-
ting fibroblasts.
Studies of the influence of breast fibroblasts on the growth
of breast cancer cells in vitro, have provided conflicting
results. Mukaida et al. (1991) demonstrated that fibroblasts
from mammary gland tissue increased the growth of MCF-7
cells when co-cultured in double layer soft agar. However,
conditioned medium from these fibroblasts failed to stimulate
MCF-7 cell growth in both anchorage independent and
anchorage dependent growth assays. Adams et al. (1988a)
demonstrated that conditioned medium from fibroblasts de-
rived from malignant and benign breast tumours increased
the growth of the human breast cancer cell line MCF-7 in
vitro. As they used a serum based culture system, interaction
between growth factors in the serum and proteins in the
conditioned medium may be responsible for the stimulation
in breast cancer cell growth. This laboratory (Ryan et al.,
1991) and others (Van Roozendaal et al., 1992) have demon-
strated that fibroblast-conditioned medium stimulates breast
cancer cell growth in serum free culture, indicating the prod-
uction of a mitogenic factor by human fibroblasts.
In this paper, we investigate the importance of fibroblast
derived products in paracrine stimulation of human breast
cancer cells in vitro using a serum free assay system. We
compare the mitogenic activity of fibroblast-conditioned me-
dium with that of both benign and malignant epithelia and
endothelium. Finally, we investigate the characteristics of the
factor or factors present in fibroblast-conditioned medium
that are mitogenic for human breast cancer cells in vitro.
Materials and methods
All chemicals were supplied by Sigma Chemical Co, Dorset,
UK. Except where specifically noted.
Tissue culture media
The basic tissue culture media used throughout was DMEM/
F12 1:l(phenol red free) supplemented with 15 mM HEPES,
2.2 g 1i sodium bicarbonate and the antibiotics Benzyl-
penicillin (Glaxo Lab Ltd, Greenford UK) 50 units ml-',
Streptomycin (Evans Medical Ltd, Greenford UK) 100tLg
ml-' and Amphotericin B (Squibb, Hounslow, UK) 2 pg
ml-'. This is referred to as serum free medium (SFM).
For routine maintenance of fibroblasts and the breast
cancer cell lines SFM was supplemented with human mono-
component insulin 0.12 iu ml-' (Novo Industries, Romford,
UK), hydrocortisone 4 jig ml-' (Upjohn Ltd, Crawley, UK)
and 10% Fetal Calf Serum (FCS) (Gibco Ltd, Paisley, UK)
referred to as complete medium (CM). Non malignant breast
epithelia were maintained in CM further supplemented with
cholera toxin (10 ng ml-') and epidermal growth factor
(EGF) (I0 ng ml-').
The malignant breast cell lines were grown in basal med-
ium containing dextran/charcoal stripped 10% FCS (DCC-
CM) for 48 h prior to growth assays. The cells were grown in
serum free medium supplemented with BSA (200tLg ml-')
and transferrin (10glgml-') (SFM-BSA/Tf) during prolifera-
tion assays.
Primary cultures ofbreastfibroblasts and epithelia
Samples of breast tissue and a wound biopsy were dissected
free of fat and cut into small (1-5 mm) pieces.
The dissected tissue was subjected to collagenase digestion
(0.5 mg ml-' collagenase) and the samples mixed overnight
on a blood wheel at 37'C. The digest was centrifuged, 5 ml of
fresh media added and allowed to sediment under gravity for
20 min at room temperature. The initial supernatant was
plated into tissue culture flasks as a fibroblast-rich suspen-
sion. The sedimentation process was repeated and subsequent
supernatants and the final cell sediment were plated as
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sources of mixed fibroblast/epithelial cultures. After 5-7
days incubation, when epithelial colonies were well estab-
lished, the cultures were differentially trypsinised to detach
fibroblasts from the flask while leaving the epithelial cells
attached. Fourteen fibroblast cell lines were established: four
from fibroadenoma tissue, four from normal breast paren-
chyma adjacent to benign and malignant breast disease, three
from malignant breast tissue, two from breast skin tissue and
one from a granulating wound. Fibroblasts only survived in
short term culture and were used between passages two and
12. They did not form tumours when injected into nude mice,
and demonstrated typical fibroblast morphology in culture.
The fibroblast cultures were confirmed as fibroblasts by stain-
ing with the monoclonal antibody Dako-Fibroblast 5B5
(Dako Ltd, High Wycombe, UK) which reacts with the
P-subunit of prolyl-4-hydroxylase and with the disulphide
isomerase.
Breast tumour cell lines
Five breast cancer cell lines were utilised: MCF-7, T47D,
MDA-MB-231, MDA-MB-436, and ZR-751. MCF-7, T47D
and MDA-MB-436 were obtained as generous gifts from Dr
Colby Eton (Tenovus Cancer Research Institute, Cardiff
UK). MDA-MB-231 and ZR-751 from Dr Marc Lippman
(NIH, Bethseda, Maryland, USA) and Dr W.R. Miller
(Imperial Cancer Research Fund, Medical Oncology Unit,
Western General Hospital, Edinburgh, UK) respectively.
Endothelial cells
Primary endothelial cells (MENDO 1) that had been isolated
from a human umbilical vein and grown in short term cul-
ture were supplied by Mr Simon Evans (Dept. Haematology,
UWCM, Cardiff, UK). The endothelial cultures were demon-
strated to contain greater than 95% cells that stained positive
for Von Willebrand's factor using a monoclonal antibody
Dako-factor VIII (Dako Ltd, High Wyecombe, UK).
Preparation ofconditioned medium
Cells were grown in CM until 75-90% confluency, washed
twice with SFM and grown in SFM for 24 h. For the pur-
poses of comparison between different fibroblasts, identical
numbers of cells (106) were used to produce 15 ml of condi-
tioned medium. The conditioned medium was collected and
centrifuged at 3000 RPM in a bench top centrifuge for
15 min and filtered through a 0.2 gm filter. The filtrate was
stored at - 20°C until required. Forty-eight hours prior to
the production of epithelial cell conditioned medium cholera
toxin and EGF were removed from the medium.
Growth assay
Breast tumour cell lines were plated into 96-well microtitre
plates (Nunc, Denmark) at a concentration of 5000 cells
(1,250 cells MDA-MB-231) per well in SFM containing 5%
DCC-FCS. After 24 h the plates were washed twice with
SFM and varying dilutions of fibroblast, epithelial or endo-
thelial cell conditioned medium or concentrations of known
growth factors were added in SFM-BSA/Tf. The concentra-
tions of BSA and transferrin were maintained constant in all
experiments. The cultures were incubated for between 1 and
7 days and the effects on growth measured.
MTT assay
Cell proliferation was measured using a colourimetric assay
(Mossman, 1983) based on the ability of viable cells to
convert a soluble tetrazolium salt, 3,[4,5-Dimethylthiazol-2-
yl]-2,5,-diphenyltetrazolium bromide (MTT) into an insoluble
formazan precipitate. Following initial calibration experi-
ments, the assay was modified from the procedure of Twen-
tyman and Luscombe (1987). Twenty jil MTT (2.5 mg ml-'
Phosphate Buffered Saline pH 7.2) was added for 4 h and all
medium was removed leaving purple crystals of insoluble
tetrazolium at the bottom of the wells. The crystals were
redissolved by the addition of 200 slI DMSO and the absor-
bance was measured in a Titertek multiwell spectrophoto-
meter at 550 nm.
Tritiated thymidine assay
Cells were grown for 20 h, following which, 3[H]-thymidine
(Amersham UK plc) was diluted in thymidine containing
medium and added to each well at a final concentration of
2tici ml-' for a period of 8 h. Subsequently the medium was
removed, the cells incubated for 15min in ice cold 10%
TCA, washed three times in 5% TCA for 5 min, lysed over-
night in 0.5 M NaOH and the incorporated radioactivity
quantified by scintillation counting.
Characterisation ofthe mitogenic component in
fibroblast-conditioned medium
Heat stability Conditioned medium was heated to 56°C and
100°C for 30 min and the stimulatory activity tested on
MCF-7 cells.
Trypsin sensitivity
Trypsin at a concentration of 1Olgml-' was added to
fibroblast-conditioned medium and incubated for 1 h at 37°C.
The effect of the trypsin was neutralised by the addition of
soyabean trypsin inhibitor at a concentration of 20jig ml-'.
As a control conditioned medium was incubated for 1 h with
trypsin 10 tLg ml-' together with trypsin inhibitor, 20;tg ml-'
at 37°C. Recovery of mitogenic activity following trypsin
exposure was calculated as a percentage of this control.
Stability to reducing agents
Dithiothreitol was added to fibroblast-conditioned medium at
a final concentration of 50 mM for 1 h at room temperature,
the medium was then dialysed at 4°C against three changes of
SFM using Spectra/Por 3 dialysis tubing (Spectrum Medical
Industries, Inc, USA) and mitogenic activity assayed.
Acidand ionic stability
Fibroblast-conditioned medium was dialysed for 4 h against
1 M acetic acid and distilled water at 4°C using Spectra/Por 3
dialysis tubing (mol wt cut off. 3,500) (Spectrum Medical
Industries, Inc, USA). The pH of acid treated medium was
demonstrated to have fallen to pH 2.0. The medium was then
dialysed against SFM until the pH of the acid treated
medium had returned to 7.3. Mitogenic activity was then
assayed. As a control, fibroblast-conditioned medium was
dialysed for 4 h against SFM and the activity recovered
following dialysis against acid and distilled water calculated
as a percentage of this control.
Heparin binding
Twenty-five ml of fibroblast-conditioned medium was added
to a 5 ml Hi-trap Heparin (Pharmacia-LKB Sweden) affinity
column. The unabsorbed material was collected and the
mitogenic activity compared to that of untreated conditioned
medium. The column was then eluted with increasing concen-
trations of NaCl in 20 mM tris buffer pH 7.2. Fractions were
collected and dialysed against three changes of SFM using
Spectra/Por 3 dialysis tubing (Spectrum Medical Industries,
Inc, USA). The mitogenic activity of each fraction was
assayed.
Sephadex G-75 column
Fibroblast-conditioned medium was purified using a modifi-
cation of the procedure described by Adams et al. (1988b).
Fibroblast-conditioned medium was concentrated 10 fold by1270 M.C. RYAN et al.
ultrafiltration using a YM2 filter (mol wt cut off 1000)
(Amicon Ltd, UK). The concentrate was then added to a
Sephadex G-75 column (1.65 cm x 65 cm). The sample was
eluted from the column under gravity with 250 ml PBS
(pH 7.4) at 4°C. Fractions (4 ml) were collected, sterilised by
passage through a 0.2gm Millipore filter and tested immed-
iately at a 20% v/v concentration.
The Mann-Whitney test was used for statistical analysis.
Results
Effect offibroblast-conditioned medium on MCF-7 cells in
serumfree culture
MCF-7 cells grown in SFM-BSA/Tf grow slowly but remain
viable. Addition of fibroblast-conditioned medium stimulated
growth in a dose-dependent manner (Figure 1), with 50%
conditioned medium producing a 119% increase over cells
grown in SFM-BSA/Tf at day 7 (P<0.01). Fibroblast-
conditioned medium increased cell growth to 90% of that
produced by cells grown in complete medium containing 5%
FCS.
Comparison ofgrowth assays
To prove that the increase in MTT absorbance reflected a
genuine increase in cell number rather than an increase in cell
respiration, we compared the effect of fibroblast-conditioned
medium on MTT absorbance after 6 days in culture and on
3[H]-thymidine uptake after 28 h (Figure 2). The fibroblast-
conditioned medium increased 3[H]-thymidine uptake and
MTT absorbance in a concentration dependent manner. At a
50% dilution in SFM (BSA/Tf), conditioned medium pro-
duced an increase in 3[H]-thymidine of 132.5% (P<0.01) an
increase in MTT absorbance of 102.2% (P<0.01) over cells
grown in SFM (BSA/Tf).
Effect offibroblast-conditioned mediumfrom different cell lines
To determine that growth stimulation was not a characteris-
tic of one particular fibroblast cell line, the effect of 14
different fibroblast conditioned media on MCF-7 cell growth
was measured. The results are presented in Table I. All tested
fibroblasts produced conditioned medium that was stimula-
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Figure 1 Response of MCF-7 cells to BBF-10 fibroblast-
conditioned medium. Growth in SFM (0-0), in CM (0-0), in
SFM-BSA/Tf (--), in 25% (A-A), in 50% (v-V) and 100%
(v-v) fibroblast-conditioned medium, as measured by the MTT
assay. Results are shown as mean ± standard error.
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Figure 2 Comparison of growth assays for BBF-10 fibroblast
stimulation of MCF-7 cells. MTT (0-0) colourimetric assay
after 6 days growth, 3[H]-thymidine uptake (0-0) after 28 h in
culture. Results shown as mean ± standard deviation (n = 6).
Table I Comparison of mitogenicity for MCF-7 cells ofconditioned
medium from fibroblasts of different tissue sources
Fibroblast line Tissue source % Stimulation ± s.e.m.
KB16F Fibroadenoma 73.3% ± 8.9%
DB1OF Fibroadenoma 119.8% ± 7%
MB1F Fibroadenoma 68.2% ± 1.8%
MB2F Fibroadenoma 31.8% ± 2.6%
MB3F Normal breast 123.4% ± 5%
BBF1 Normal breast 98% ± 5.4%
BBF5 Normal breast 83.5% ± 6.5%
BBFIO Normal breast 121.9% ± 3.7%
BTF1 Malignant breast 114% ± 5.3%
BTF3 Malignant breast 48.1% ± 5.6%
BTF9 Malignant breast 66.8% ± 4.6%
SFI Skin 99.2% ± 6.2%
SF2 Skin 60.7% ± 2.9%
WF2 Granulating wound 31.3% 4.3%
tory for MCF-7 cell growth in serum free medium indepen-
dent of tissue source. The degree of stimulation varied from
31.3% to 123.4% increase in MCF-7 cell growth. The
numbers ofcell lines in each group are too few to discern any
differences in the degree of stimulation induced by fibroblasts
of different tissue origin.
Effect offibroblast-conditioned medium on a number ofbreast
cancer cell lines
The stimulatory effects of fibroblast-conditioned medium for
a number of different breast cancer cell lines in serum free
medium, are shown in Figure 3. The results are presented as
increase in DPM and MTT absorbance over cells grown in
SFM (BSA/Tf), as the individual cell lines grow at different
rates in this medium. The fibroblast-conditioned medium was
stimulatory for all the tested breast cell lines. 3[H]-Thymidine
was increased by 132.5% in MCF-7 cells, 135.4% in T47D
cells, 111.9% in MDA-MB-231 cells, 107.1% in MDA-MB-
436 cells and 102.6% in ZR-751 cells at a dilution of
fibroblast-conditioned medium of 50% in SFM (BSA/Tf)
(P<0.01) (Figure 3a). Fibroblast-conditioned medium at a
concentration of 50% increased MTT absorbance after 6
days in culture, for MCF-7, T47D, MDA-MB-231, MDA-
MB-436 and ZR-751 by 53.9%, 59.5%, 66.6%, 48.8% and
37.1% respectively [P<0.01] (Figure 3b).FIBROBLAST STIMULATION OF BREAST CANCER CELLS 1271
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a The effect ofpolypeptide growvth frctors on MCF-7 cells
The effects of a number of polypeptide growth factors on the
growth of MCF-7 breast cancer cells in vitro were determined
(Figure 5).
EGF was a potent mitogen at a concentration of 10 ng
ml', increasing MTT absorbance by 116.3% over control
cells. Insulin-like growth factors were also mitogenic, in the
order of potency IGF1 > IGF2> insulin increasing cell
growth by 131.7%, 75.2%, and 19% respectively. PDGF and
TGF-J3 induced no significant increase in growth. These
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Figure 4 Comparison of the effect of conditioned medium from
fibroblast, endothelial, benign breast epithelial and malignant
breast epithelial cell lines on the growth of MCF-7 breast cancer
cells in vitro. MB3F fibroblast-conditioned medium (0-0),
Mendo I endothelial-conditioned medium (A-A), MB3E benign
epithelium-conditioned medium (G--), T47D malignant
epithelium-conditioned medium (*-*). Growth measured by the
MTT colourimetric assav after 6 days in culture, results presented
as mean % increase in absorbance at 550 nm ± standard error
(n = 6).
Figure 3 Effect of BBF-10 fibroblast-conditioned medium on the
growth of five breast cancer cell lines a, Effect on 3[H]-thymidine
uptake after 28 h in culture; b, Effect on MTT absorbance after 6
days in culture. MCF-7 (S-*), T47D (0-0), MDA-MB-231
(*-*), MDA-MB-436 (V-V). ZR.75-1 (A iA) Results pre-
sented as means ± standard error.
** **
Comparison ofconditioned mediumfrom breastfibroblasts,
benign breast epithelia, malignant breast epithelia, and
endothelia
Undiluted benign epithelial conditioned medium inhibited
MCF-7 cell growth (28.9% P<0.01), however dilution to
50% in SFM (BSA/TF) produced a small but significant
increase in MCF-7 cell growth with a 22.7% increase in
MTT absorbance (P<0.01) (Figure 4). Malignant epithelial
conditioned medium was not mitogenic, in undiluted form
producing a significant inhibition of MCF-7 cells (11.8%
P<0.05) (Figure 4). Similar results with malignant epithelial
conditioned medium have been reported (Van der Burg et al.,
1990). Endothelial cells were highly stimulatory, their condi-
tioned medium causing significant increases in MTT ab-
sorbance, 98.4% (P<0.01) at a dilution of 50% in SFM
(BSA/Tf) (Figure 4). Endothelial cells were found to be the
only other cell type, beside fibroblasts to stimulate the
growth of human tumours as xenotransplants in athymic
mice (Picard et al., 1986) suggesting that mesenchymal cells
produce mitogenic factors for human tumour cells.
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Figure 5 Effect of polypeptide growth factors on the growth of
MCF-7 breast cancer cells in vitro as measured by the MTT
colourimetric assay after 6 days in culture. Growth in SFM-BSA/Tf
(0), in SFM-BSA/Tf plus 10 ng ml-' polypeptide growth factor
(U). Results presented as mean ± s.e. (n = 6). **P <0.01, *P <0.05,
n.s. = not significant.
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results concur with the report of Karey and Sirbasku (1990)
and confirm that the effects of known mitogens were detec-
table in our assay system.
Characterisation ofthe mitogenic component of
fibroblast-conditioned medium
The effect of heat, trypsin, dithiothreitol, acid and ionic
treatment on the mitogenic activity of fibroblast-conditioned
medium is presented in Table II.
The mitogenic component of fibroblast-conditioned med-
ium is relatively heat and acid stable with exposure to 100°C
and 1 M acetic acid reducing the activity to 38% and 48% of
control levels respectively, whereas dialysis against distilled
water reduces the mitogenic activity to 22%. The protein
nature of the mitogenic component is confirmed by the
reduction in activity to 55% following exposure to trypsin
and total loss of activity following dithiothreitol treatment.
Fibroblast-conditioned medium that had been passed
through a heparin column was as stimulatory as untreated
conditioned medium, and the fractions collected following
elution with increasing concentrations of NaCl were found to
contain no stimulatory activity.
Fibroblast-conditioned medium was subjected to a crude
purification on a Sephadex G-75 column. The effect of indi-
vidual fractions on the growth of MCF-7 cells in SFM
(BSA/Tf) is presented as MTT absorbance (Figure 6). The
values for fractions obtained from conditioned medium are
shown alongside values obtained from purification of SFM.
In three separate fractionations a peak of increased cell
growth was detectable at fraction 14, which corresponds to a
molecular weight of 8,000 Da approximately.
Table II Physico-chemical characteristics of the mitogenic
component of fibroblast conditioned medium
Treatment % activity recovered
56°C for 30 min 79.2%
100°C for 30min 38.3%
Trypsin IOfigml- 1 h 37'C 55%
50mM Dithiothreitol for 1 h 0%
Acid dialysis to pH 2 48%
Dialysis against distilled H20 22%
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Figure 6 Fractionation of KB16F fibroblast-conditioned medium on
a Sephadex G-75 column. Effect of individual fractions on the
growth of MCF-7 cells. Growth was measured after 6 days in culture
by the MTT colourimetric assay. Fractions of fibroblast-conditioned
medium (0-0), molecular weight markers (*-*) (Haemoglobin,
Cytochrome C, Dinitrophenol). This profile is the mean of three
separate experiments.
Discussion
The results demonstrate that conditioned media from short
term cultures of human fibroblasts are mitogenic for a
number of human breast cancer cell lines, increasing both
DNA synthesis in short term culture and cell number in a
more long term proliferation assay. These findings support
the concept that stromal cells may play an important role in
the regulation of human breast tumour growth, through the
production of factors that modulate the proliferation of
tumour epithelia (Lippman et al., 1986a; 1986b; Yee et al.,
1988; 1989; Cullen et al., 1991).
Van Roozendaal et al. (1992), using a serum free culture
system and the MTT proliferation assay, demonstrated that
breast tumour cells responded differently to fibroblast-con-
ditioned medium: the steroid receptor positive cell lines
MCF-7 and ZR 75.1 were stimulated to grow, whereas the
steroid receptor negative cell lines MDA-MB-231 and Evsa-T
showed little or no proliferative response. We have demon-
strated that fibroblast-conditioned medium increased radio-
active thymidine uptake and MTT absorbance in all tested
breast cancer cells.
Although it has been demonstrated that fibroblast stimula-
tion of human breast cancer cell growth in vivo is indepen-
dent of tissue source (Horgan et al., 1987), Mukaida et al.
(1991) reported that only fibroblasts from human mammary
tissue and lung stimulated MCF-7 cell growth in a double
layer soft agar assay. Fibroblasts from other tissues had no
effect or were inhibitory. Adams et al. (1988a) reported that
fibroblasts derived from malignant and benign breast tum-
ours produced conditioned medium that stimulated MCF-7
cell growth in vitro, whereas fibroblasts derived from reduc-
tion mammoplasty tissue were inhibitory. Van Roozendaal et
al. (1992) found that all fibroblasts, regardless of tissue
source, stimulated MCF-7 growth in vitro. Our data concurs
with this finding. However, they reported that the extent of
the proliferative response was dependent on the source of the
isolated fibroblasts. Tumour and skin fibroblasts induced a
greater mitogenic effect on MCF-7 cells than those isolated
from benign breast tissue.
Comparison of conditioned medium from fibroblast, be-
nign epithelial, malignant epithelial and endothelial cell cult-
ures showed that only cells derived from mesenchymal tissues
were mitogenic for MCF-7 cells.
There is little information in the literature as to the nature
and identity of the factors present in fibroblast-conditioned
medium that stimulate the proliferation of tumour epithelia.
Characterisation of the mitogenic component of fibroblast-
conditioned medium demonstrates that after boiling for
30 min a residual activity of 30% remains and reduction to
pH 2.0 reduces activity by half. The protein nature of the
mitogenic component is suggested by the fact that it is sen-
sitive to dithiothreitol and proteolytic enzyme treatment. The
mitogenic component of fibroblast-conditioned medium has
no affinity for heparin, therefore heparin binding growth
factors such as basic and acidic fibroblast growth factors can
be ruled out as the mitogenic factor in the conditioned
medium. Partial purification of fibroblast-conditioned med-
ium demonstrated that the cells secrete a mitogenic factor for
MCF-7 cells with a molecular weight ofapproximately 8,000.
TGF-a and the insulin like growth factors are small polypep-
tides with molecular weights similar to the factor identified
and both factors have been shown by ourselves and others to
be potent mitogens for MCF-7 cells in vitro (Karey & Sir-
basku 1988; Van der Burg et al., 1990; Osborne et al., 1989,
1990). However, at the neutral pH at which the fibroblast-
conditioned medium was extracted from the Sephadex col-
umn, IGFs would be expected to be bound to high affinity
binding proteins and would elute at a much higher molecular
weight. Normally, acid extraction would be required to ex-
tract free IGFs (Hintz, 1984).
IGF-I and IGF-II have been shown to be produced by
human fibroblasts in vitro (Clemmons, 1984). In situ hyb-
ridisation studies (Yee et al., 1989) have shown that IGF-I
mRNA is expressed in the stromal tissue of breast tumours
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but not in the epithelial cells. Cullen et al. 1991 have demon-
strated that short term cultures of fibroblasts isolated from
benign tumours express high levels of IGF-I mRNA whereas
fibroblasts isolated from malignant tumours express high
levels of IGF-II mRNA. They also examined a panel of
breast tumour cell lines (containing both oestrogen receptor
positive and negative phenotypes) and breast cancer speci-
mens. Messenger RNA encoding for IGF-I, IGF-II and
Insulin receptors was present in virtually all samples tested
(Cullen et al., 1990). It has been suggested that the IGFs
function as stromal derived factors that play an important
role in the paracrine regulation of human breast cancer (Yee
et al., 1988; 1989; Cullen et al., 1991). Clarke et al. (1992)
dispute this hypothesis. While acknowledging that stromal
fibroblasts secrete IGFs, they suggest that the IGFs act as
autocrine factors inducing increased fibroblast growth. They
point out that IGF production must be sufficient both to
saturate the IGF receptors on stromal cells and to avoid
inactivation by tumour produced inhibitory insulin binding
proteins (Clemmons et al., 1990).
The experiments detailed in this paper clearly demonstrate
that fibroblasts secrete factors that stimulate human breast
cancer in vitro. These factors may play an important role in
the paracrine regulation of human breast cancer by stromal
cells. Partial purification of the fibroblast-conditioned med-
ium suggests that they secrete a non-heparin-binding peptide
with a molecular weight very close to that of the IGFs and
TGF-o. Further study is required to characterise or isolate
fibroblast derived growth factors and to determine their role
in epithelial-stromal interaction in the human breast.
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